Furin and the Etiopathogenesis of UV-Induced Skin Cancer
弗林蛋白酶和紫外线诱发的皮肤癌的发病机制
基本信息
- 批准号:7795923
- 负责人:
- 金额:$ 36.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:Biological ProcessBiomedical EngineeringCell ProliferationComplementary DNADevelopmentEarly DiagnosisEnzymesEpidermisExperimental Animal ModelFamilyGrowthGrowth FactorGrowth Factor ReceptorsGrowth and Development functionHumanImpairmentLeadMMP11 geneMalignant NeoplasmsMatrix MetalloproteinasesModelingMusPathogenesisPeptide HydrolasesPeptidesPhysiologicalPlayPredispositionPremalignantProcessProprotein Convertase 2Proprotein ConvertasesProteinsProtocols documentationPublic Health Applications ResearchRelative (related person)RoleSeriesSkinSkin CancerSkin CarcinogenesisSkin NeoplasmsSquamous cell carcinomaSubstrate SpecificityTestingTransgenic AnimalsTransgenic MiceTransgenic ModelTransgenic OrganismsUV Radiation ExposureUV carcinogenesisUV inducedUltraviolet Raysbasecancer cellcarcinogenesisdesignin vivoinhibitor/antagonistkeratinocytemouse modelneoplasticneoplastic celloverexpressionpublic health relevancereceptorresearch studysynergismtumortumor growth
项目摘要
DESCRIPTION (provided by applicant): Furin is a protein processing enzyme of the family of proprotein convertases (PCs), which has a significant role in cancer etiopathogenesis. In this application, we propose to investigate the function of furin during skin tumor development, focusing on the early and late changes that take place after UV exposure of the mouse skin. PACE4, another related PC, has been shown to have a role in murine tumor cell invasiveness by activating relevant proteases. Furin is also able to enhance cell proliferation in human precancerous and cancer cells by activating growth factor and growth factor receptors, such as IGF-R1. The lack of a mouse model to study the function of furin during carcinogenesis prompted us to design a series of experiments using transgenic mice to facilitate the better understanding of this prominent PC in the etiopathogenesis of skin cancer. Our objective in this proposal is to determine the mechanisms by which furin contributes to tumor development alone or in combination with PACE4 using transgenic mice overexpressing PCs. Two aims have been designed to this effect: First we will determine if the targeted in vivo overexpression of furin alone will enhance the development of experimental skin cancer induced by UV. We shall investigate the simultaneous in vivo overexpression of PACE4 and furin using bigenic mice in order to establish the possible cooperation of the 2 PCs in skin carcinogenesis. Substrate- specificity will be evaluated in keratinocyte cultures derived from monogenic (K5-PACE4 and K5-Furin) as well as from bigenic mice (K5-PACE4/Furin). These experiments will clarify the significance of furin's pro-proliferative effect and whether its pro-invasive effects are the same or different from PACE4's predominant pro-invasive function. In addition, this specific aim will determine whether the combination of both PCs have an enhancing effect on any or both of these biological processes. Second, we will also determine if PC inhibition blocks tumor growth and development in transgenic models. Crossing monogenic PC transgenic mice as well as double transgenics K5-Furin/PACE4 with K5-PDX and K5-PC-Propeptide transgenic mice expressing either the cDNA of a competitive PC peptide inhibitor or that of the physiological inhibitors of PCs, we will determine if inhibition of PCs alters the formation of skin tumors induced by UV carcinogenesis. PUBLIC HEALTH RELEVANCE: This application will use modern experimental animal models to dissect the function of proprotein convertases, enzymes that activate relevant cancer-associated biomolecules, during the early formation and growth of squamous cell carcinomas, one of the most common cancers of the human skin. The proposed studies will lead to the identification of mechanisms involved in the origination of cancer that could be of great practical value in its early diagnosis and treatment.
描述(由申请人提供):Furin是一种蛋白质加工酶的蛋白质加工酶(PCS),在癌症疗法发生中具有重要作用。在此应用中,我们建议研究皮肤肿瘤发育过程中FURIN的功能,重点关注小鼠皮肤紫外线暴露后发生的早期和晚期变化。 PACE4是另一个相关的PC,已证明通过激活相关蛋白酶在鼠肿瘤细胞的侵袭性中起作用。 FURIN还能够通过激活生长因子和生长因子受体(例如IGF-R1)来增强人癌细胞和癌细胞中的细胞增殖。缺乏小鼠模型来研究癌过程中弗林的功能,促使我们设计了一系列使用转基因小鼠的实验,以促进对皮肤癌的病情发生中对该突出的PC的更好理解。我们在该提案中的目标是确定FURIN单独使用过表达PC的转基因小鼠与PACE4相结合的机制。已经设计了两个目的是为了这一效果:首先,我们将确定靶向的体内过度表达是否单独使用FURIN,从而增强紫外线诱导的实验性皮肤癌的发展。我们将使用临后小鼠同时研究PACE4和FURIN的体内过度表达,以确定皮肤癌变中2个PC的可能合作。底物特异性将在源自单基因(K5-PACE4和K5-氟林)以及bigenic小鼠(K5-PACE4/Furin)的角质形成细胞培养物中进行评估。这些实验将阐明Furin促增殖作用的重要性,以及其促侵入性效应是否与PACE4的主要促侵入性功能相同或不同。此外,这一特定目的将决定这两种PC的组合是否对这些生物过程中的任何或两个都有增强的影响。其次,我们还将确定PC抑制是否会阻断转基因模型中的肿瘤生长和发育。 Crossing monogenic PC transgenic mice as well as double transgenics K5-Furin/PACE4 with K5-PDX and K5-PC-Propeptide transgenic mice expressing either the cDNA of a competitive PC peptide inhibitor or that of the physiological inhibitors of PCs, we will determine if inhibition of PCs alters the formation of skin tumors induced by UV carcinogenesis.公共卫生相关性:本应用将使用现代的实验动物模型来剖析普罗蛋白转化酶的功能,即激活相关癌症相关的生物分子的酶,在鳞状细胞癌的早期形成和生长中,这是人类皮肤最常见的癌症之一。拟议的研究将导致鉴定癌症起源的机制,这些机制在早期诊断和治疗中可能具有巨大的实际价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDRES J KLEIN-SZANTO其他文献
ANDRES J KLEIN-SZANTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDRES J KLEIN-SZANTO', 18)}}的其他基金
Furin and the Etiopathogenesis of UV-Induced Skin Cancer
弗林蛋白酶和紫外线诱发的皮肤癌的发病机制
- 批准号:
8212347 - 财政年份:2009
- 资助金额:
$ 36.21万 - 项目类别:
Furin and the Etiopathogenesis of UV-Induced Skin Cancer
弗林蛋白酶和紫外线诱发的皮肤癌的发病机制
- 批准号:
8029552 - 财政年份:2009
- 资助金额:
$ 36.21万 - 项目类别:
Furin and the Etiopathogenesis of UV-Induced Skin Cancer
弗林蛋白酶和紫外线诱发的皮肤癌的发病机制
- 批准号:
7576602 - 财政年份:2009
- 资助金额:
$ 36.21万 - 项目类别:
Tissue Arraying, Immunostaining, and Imaging System
组织阵列、免疫染色和成像系统
- 批准号:
7388654 - 财政年份:2008
- 资助金额:
$ 36.21万 - 项目类别:
The Role of VILIP-1 in Development of Skin Tumors
VILIP-1 在皮肤肿瘤发展中的作用
- 批准号:
7097961 - 财政年份:2005
- 资助金额:
$ 36.21万 - 项目类别:
The Role of VILIP-1 in Development of Skin Tumors
VILIP-1 在皮肤肿瘤发展中的作用
- 批准号:
6993466 - 财政年份:2005
- 资助金额:
$ 36.21万 - 项目类别:
The Role of VILIP-1 in Development of Skin Tumors
VILIP-1 在皮肤肿瘤发展中的作用
- 批准号:
7271433 - 财政年份:2005
- 资助金额:
$ 36.21万 - 项目类别:
相似国自然基金
基于稀疏表示模型和先验结构信息的低剂量PET/MRI成像研究
- 批准号:81871441
- 批准年份:2018
- 资助金额:58.0 万元
- 项目类别:面上项目
基于多级弹簧腿系统的外骨骼下肢康复机器人协动原理研究
- 批准号:51505191
- 批准年份:2015
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
结合DNA杂交编码的受体和细胞微阵列仿生味觉传感器的研究
- 批准号:31470956
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
ECoG,EEG-fMRI多模态癫痫监测与病灶定位研究
- 批准号:81471743
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
FGFR特异性核酸适体的筛选及在分子标记和靶向药物载体中的应用
- 批准号:81471773
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
相似海外基金
Preclinical microphysiological tumor models for nuclear medicine
核医学临床前微生理肿瘤模型
- 批准号:
10587674 - 财政年份:2023
- 资助金额:
$ 36.21万 - 项目类别:
Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
- 批准号:
10588085 - 财政年份:2023
- 资助金额:
$ 36.21万 - 项目类别:
Lens Epithelial Cell Response to Biomaterial Interfaces
晶状体上皮细胞对生物材料界面的反应
- 批准号:
10372517 - 财政年份:2022
- 资助金额:
$ 36.21万 - 项目类别:
Lens Epithelial Cell Response to Biomaterial Interfaces
晶状体上皮细胞对生物材料界面的反应
- 批准号:
10544163 - 财政年份:2022
- 资助金额:
$ 36.21万 - 项目类别:
Organoid modeling of pre-metastatic niche formation in the liver by primary colorectal tumor secreted factors
原发性结直肠肿瘤分泌因子在肝脏中形成转移前生态位的类器官模型
- 批准号:
10686798 - 财政年份:2022
- 资助金额:
$ 36.21万 - 项目类别: